A Clinical Study to Investigate the Effect of an Investigational Drug on Electrocardiogram Intervals in Adults With Schizophrenia.

NCT04369391 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: SEP363856 150 mg
DRUG: Placebo
DRUG: moxifloxacin 400 mg

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.